Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barré syndrome and other neurological disorders

Clinica Chimica Acta

Volumn 405, Issue 1-2, 2009, Pages 143-147

  Chiang, Han Lin ^a   Lyu, Rong Kuo ^a   Tseng, Mu Yun ^a   Chang, Kuo Hsuan ^a   Chang, Hong Shiu ^a   Hsu, Wen Chuin ^a   Kuo, Hung Chou ^a   Chu, Chun Che ^a   Wu, Yih Ru ^a   Ro, Long Sun ^a   Huang, Chin Chang ^a   Chen, Chiung Mei ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Cerebrospinal fluid; Guillain Barr syndrome; Transthyretin

Indexed keywords

PREALBUMIN;

ADULT; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEMYELINATING DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL ELECTROPHORESIS; GUILLAIN BARRE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MULTIPLE SCLEROSIS; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; VIRUS MENINGITIS;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PREALBUMIN;

EID: 67349125374     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.04.022     Document Type: Article

References (42)

1. Hughes R.A., and Cornblath D.R. Guillain-Barré syndrome. Lancet 366 (2005) 1653-1666
2. Asbury A.K., Arnason B.G., and Adams R.D. The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore) 48 (1969) 173-215
3. Cosi V., and Versino M. Guillain-Barré syndrome. Neurol Sci 27 Suppl 1 (2006) S47-S51
4. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 255 (1956) 57-65
5. Chiò A., Cocito D., Leone M., Giordana M.T., Mora G., and Mutani R. Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey. Neurology 60 (2003) 1146-1150
6. Chang K.H., Lyu R.K., Tseng M.Y., et al. Elevated haptoglobin level of cerebrospinal fluid in Guillain-Barré Syndrome revealed by proteomics analysis. Proteomics Clin Appl 1 (2007) 467-475
7. Yang Y.R., Liu S.L., Qin Z.Y., et al. Comparative proteomics analysis of cerebrospinal fluid of patients with Guillain-Barré syndrome. Cell Mol Neurobiol 28 (2008) 737-744
8. Jin T., Hu L.S., Chang M., Wu J., Winblad B., and Zhu J. Proteomic identification of potential protein markers in cerebrospinal fluid of GBS patients. Eur J Neurol 14 (2007) 563-568
9. Lehmensiek V., Sussmuth S.D., Brettschneider J., et al. Proteome analysis of cerebrospinal fluid in Guillain-Barré syndrome (GBS). J Neuroimmunol 185 (2007) 190-194
10. 2 synthase in the cerebrospinal fluid of patients with acute inflammatory demyelinating polyneuropathy. J Neuroimmunol 206 (2009) 100-105
11. Asbury A.K., and Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 27 (1990) S21-S24 [Suppl]
12. McDonald W.I., Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50 (2001) 121-127
13. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
14. Van den Bergh P.Y., and Piéret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 29 (2004) 565-574
15. Ingenbleek Y., and Young V. Transthyretin (prealbumin) in health and disease: nutritional implications. Annu Rev Nutr 14 (1994) 495-533
16. Dickson P.W., Howlett G.J., and Schreiber G. Metabolism of prealbumin in rats and changes induced by acute inflammation. Eur J Biochem 129 (1982) 289-293
17. Rostenberg I., Rico R., and Peñaloza R. Gc globulin and prealbumin serum levels in patients with cancer and benign inflammatory diseases and in asymptomatic smokers. J Natl Cancer Inst 62 (1979) 299-300
18. Smith F.R., Goodman D.S., Zaklama M.S., Gabr M.K., el-Maraghy S., and Patwardhan V.N. Serum vitamin A, retinol-binding protein, and prealbumin concentrations in protein-calorie malnutrition. I. A functional defect in hepatic retinol release. Am J Clin Nutr 26 (1973) 973-981
19. Reiber H. Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta 310 (2001) 173-186
20. Herbert J., Wilcox J.N., Pham K.T., et al. Transthyretin: a choroid plexus-specific transport protein in human brain. The 1986 S. Weir Mitchell award. Neurology 36 (1986) 900-911
21. Kassem N.A., Deane R., Segal M.B., and Preston J.E. Role of transthyretin in thyroxine transfer from cerebrospinal fluid to brain and choroid plexus. Am J Physiol, Regul Integr Comp Physiol 291 (2006) R1310-R1315
22. Zou L., Burmeister L.A., Styren S.D., Kochanek P.M., and DeKosky S.T. Up-regulation of type 2 iodothyronine deiodinase mRNA in reactive astrocytes following traumatic brain injury in the rat. J Neurochem 71 (1998) 887-890
23. Long Y., Zou L., Liu H., et al. Altered expression of randomly selected genes in mouse hippocampus after traumatic brain injury. J Neurosci Res 71 (2003) 710-720
24. Merched A., Serot J.M., Visvikis S., Aguillon D., Faure G., and Siest G. Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry. FEBS Lett 425 (1998) 225-228
25. Stein T.D., Anders N.J., DeCarli C., Chan S.L., Mattson M.P., and Johnson J.A. Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis. J Neurosci 24 (2004) 7707-7717
26. Kunicki S., Richardson J., Mehta P.D., Kim K.S., and Zorychta E. The effects of age, apolipoprotein E phenotype and gender on the concentration of amyloid-beta (A beta) 40, A beta 4242, apolipoprotein E and transthyretin in human cerebrospinal fluid. Clin Biochem 31 (1998) 409-415
27. Reiber H. Cerebrospinal fluid-physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler 4 (1998) 99-107
28. Reiber H. CSF flow-its influence on CSF concentration of brain-derived and blood-derived proteins. In: Teelken A., and Korf J. (Eds). Neurochemistry (1997), Plenum Press, New York 423-432
29. Berlit P., and Rakicky J. The Miller Fisher syndrome. Review of the literature. J Clin Neuro-ophthalmol 12 (1992) 57-63
30. Yu R.K., Usuki S., and Ariga T. Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases. Infect Immun 74 (2006) 6517-6527
31. Trojaborg W. Acute and chronic neuropathies: new aspects of Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy, an overview and an update. Electroencephalogr Clin Neurophysiol 107 (1998) 303-316
32. Hughes R.A., Allen D., Makowska A., and Gregson N.A. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 11 (2006) 30-46
33. Press R., Pashenkov M., Jin J.P., and Link H. Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Clin Immunol 23 (2003) 259-267
34. Davidsson P., Westman-Brinkmalm A., Nilsson C.L., et al. Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients. Neuroreport 13 (2002) 611-615
35. Abdi F., Quinn J.F., Jankovic J., et al. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J Alzheimer's Dis 9 (2006) 293-348
36. Castano E.M., Roher A.E., Esh C.L., Kokjohn T.A., and Beach T. Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects. Neurol Res 28 (2006) 155-163
37. Serot J.M., Christmann D., Dubost T., and Couturier M. Cerebrospinal fluid transthyretin: aging and late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry 63 (1997) 506-508
38. Puchades M., Hansson S.F., Nilsson C.L., Andreasen N., Blennow K., and Davidsson P. Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease. Brain Res Mol Brain Res 118 (2003) 140-146
39. Lehmensiek V., Sussmuth S.D., Tauscher G., et al. Cerebrospinal fluid proteome profile in multiple sclerosis. Mult Scler 13 (2007) 840-849
40. Lamoureux G., Jolicoeur R., Giard N., St-Hilaire M., and Duplantis F. Cerebrospinal fluid proteins in multiple sclerosis. Neurology 25 (1975) 537-546
41. Krzalić L. Prealbumin content of cerebrospinal fluid and sera in persons with multiple sclerosis. Clin Chim Acta 124 (1982) 339-341
42. Larsen P.D., and DeLallo L.J. Cerebrospinal fluid transthyretin in multiple sclerosis. Neurology 37 (1987) 1262-1263